Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study

Uloženo v:
Podrobná bibliografie
Název: Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study
Autoři: Mark Schuiveling, Laurens S Ter Maat, Isabella A J Van Duin, Rik J Verheijden, Max F Troenokarso, Pim Moeskops, Joost J C Verhoeff, Sjoerd G Elias, Wouter A C van Amsterdam, Femke Burgers, Franchette W P J Van den Berkmortel, Marye J Boers-Sonderen, Martijn F Boomsma, Jan Willem De Groot, John B A G Haanen, Geke A P Hospers, Djura Piersma, Gerard Vreugdenhil, Hans M Westgeest, Ellen Kapiteijn, Mariette Labots, Wouter B Veldhuis, Paul J Van Diest, Pim A De Jong, Josien P W Pluim, Tim Leiner, Mitko Veta, Karijn P M Suijkerbuijk
Zdroj: J Natl Cancer Inst
Journal of the National Cancer Institute, 117, 6, pp. 1245-1252
Journal of the National Cancer Institute, vol. 117, no. 6, pp. 1245-1252
Informace o vydavateli: Oxford University Press (OUP), 2025.
Rok vydání: 2025
Témata: Humans, Melanoma/drug therapy, Melanoma/mortality, Melanoma/pathology, Male, Female, Immune Checkpoint Inhibitors/therapeutic use, Body Composition, Middle Aged, Aged, Body Mass Index, Retrospective Studies, Tomography, X-Ray Computed, Adult, Treatment Outcome, Progression-Free Survival, Aged, 80 and over, Netherlands/epidemiology, Skin Neoplasms/drug therapy, Skin Neoplasms/mortality, Skin Neoplasms/pathology, Intra-Abdominal Fat, Muscle, Skeletal/diagnostic imaging, Subcutaneous Fat, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Medical Oncology - Radboud University Medical Center, Article
Popis: Background The association of body composition with checkpoint inhibitor outcomes in melanoma is a matter of ongoing debate. In this study, we aim to investigate body mass index (BMI) alongside computed tomography (CT)-derived body composition metrics in the largest cohort to date. Methods Patients treated with first-line anti-PD1 ± anti-CTLA4 for advanced melanoma were retrospectively identified from 11 melanoma centers in The Netherlands. From baseline CT scans, 5 body composition metrics were extracted: subcutaneous adipose tissue index, visceral adipose tissue index, skeletal muscle index, density, and gauge. These metrics were correlated in univariable and multivariable Cox proportional hazards analysis with progression-free survival, overall survival, and melanoma-specific survival (PFS, OS, and MSS). Results A total of 1471 eligible patients were included. Median PFS and OS were 9.1 and 38.1 months, respectively. Worse PFS was observed in underweight patients (multivariable hazard ratio [HR] = 1.86, 95% CI = 1.14 to 3.06). Furthermore, prolonged OS was observed in patients with higher skeletal muscle density (multivariable HR = 0.88, 95% CI = 0.81 to 0.97) and gauge (multivariable HR = 0.61, 95% CI = 0.82 to 0.998), whereas higher visceral adipose tissue index was associated with worse OS (multivariable HR = 1.12, 95% CI = 1.04 to 1.22). No association with survival outcomes was found for overweight, obesity, or subcutaneous adipose tissue. Conclusion Our findings suggest that underweight BMI is associated with worse PFS, whereas higher skeletal muscle density and lower visceral adipose tissue index were associated with improved OS. These associations were independent of known prognostic factors, including sex, age, performance status, and extent of disease. No significant association between higher BMI and survival outcomes was observed.
Druh dokumentu: Article
Other literature type
Popis souboru: application/pdf
Jazyk: English
ISSN: 1460-2105
0027-8874
DOI: 10.1093/jnci/djaf039
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39980388
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/320183
https://doi.org/10.1093/jnci/djaf039
https://repository.ubn.ru.nl//bitstream/handle/2066/320183/320183.pdf
https://hdl.handle.net/2066/320183
https://serval.unil.ch/notice/serval:BIB_3415CBA985BE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3415CBA985BE8
https://serval.unil.ch/resource/serval:BIB_3415CBA985BE.P001/REF.pdf
Rights: CC BY
URL: http://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Přístupové číslo: edsair.doi.dedup.....b60d8226db735adc078eb100dd823b8f
Databáze: OpenAIRE
Popis
Abstrakt:Background The association of body composition with checkpoint inhibitor outcomes in melanoma is a matter of ongoing debate. In this study, we aim to investigate body mass index (BMI) alongside computed tomography (CT)-derived body composition metrics in the largest cohort to date. Methods Patients treated with first-line anti-PD1 ± anti-CTLA4 for advanced melanoma were retrospectively identified from 11 melanoma centers in The Netherlands. From baseline CT scans, 5 body composition metrics were extracted: subcutaneous adipose tissue index, visceral adipose tissue index, skeletal muscle index, density, and gauge. These metrics were correlated in univariable and multivariable Cox proportional hazards analysis with progression-free survival, overall survival, and melanoma-specific survival (PFS, OS, and MSS). Results A total of 1471 eligible patients were included. Median PFS and OS were 9.1 and 38.1 months, respectively. Worse PFS was observed in underweight patients (multivariable hazard ratio [HR] = 1.86, 95% CI = 1.14 to 3.06). Furthermore, prolonged OS was observed in patients with higher skeletal muscle density (multivariable HR = 0.88, 95% CI = 0.81 to 0.97) and gauge (multivariable HR = 0.61, 95% CI = 0.82 to 0.998), whereas higher visceral adipose tissue index was associated with worse OS (multivariable HR = 1.12, 95% CI = 1.04 to 1.22). No association with survival outcomes was found for overweight, obesity, or subcutaneous adipose tissue. Conclusion Our findings suggest that underweight BMI is associated with worse PFS, whereas higher skeletal muscle density and lower visceral adipose tissue index were associated with improved OS. These associations were independent of known prognostic factors, including sex, age, performance status, and extent of disease. No significant association between higher BMI and survival outcomes was observed.
ISSN:14602105
00278874
DOI:10.1093/jnci/djaf039